Opinion Paper The mental health implication of mpox: Enhancing care with genetic insights

Ovinuchi Ejiohuo

About the author(s) Ovinuchi Ejiohuo, Department of Psychiatric Genetics, Poznan University of Medical Sciences, Poznan, Poland; and, Molecular and Cell Biology Unit, Poznan University of Medical Sciences, Poznan, Poland

Abstract

The intersection of mpox and mental health is a critical concern, particularly for individuals with pre-existing mental disorders, who face heightened psychological stress and exacerbation of symptoms. This study explores the potential of genetic testing, such as Polygenic Risk Scores and pharmacogenetics, in enhancing mental disorders and mpox management. By tailoring treatment and prevention strategies to an individual’s genetic profile, clinicians can provide more personalised care, reducing adverse effects and improving outcomes. Furthermore, genetic insights can inform the development of safer vaccines and early interventions, particularly for vulnerable populations. The study underscores the importance of integrating mental and public health strategies, advocating for targeted research and fostering interdisciplinary collaboration to effectively address these complex health challenges.

Keywords

genetic testing; mpox; mental health; mental disorders; personalised medicine; precision psychiatry.

Sustainable Development Goal

Goal 3: Good health and well-being

Metrics Total abstract views: 58
Total article views: 52

Crossref Citations

No related citations found.